Select a community
All Communities
Home > Community Treatment Reports > Desvenlafaxine Treatment Report
What is Desvenlafaxine?

Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is an extended release formulation believed to treat depression by affecting the levels of serotonin and norepinephrine, two neurotransmitters associated with depression.

Side Effects

Side effects as an overall problem

Severe
11 28%
Moderate
4 10%
Mild
13 33%
None
12 30%

Most commonly reported side effects

Sedation
11 28%
Random Tiredness/Energy
9 23%
nausea, dizziness
6 15%
Sluggishness
6 15%
Depression
5 13%
drunk feeling
4 10%
  • Mild
  • Moderate
  • Severe

Dosages

  1 mg daily 1 other daily 2 mg daily 20 mg daily 30 mg daily 50 g daily 50 mg daily 100 mg daily 150 mg daily 200 mg daily
  3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 87 Number of Patients: 87 29 Number of Patients: 29 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Desvenlafaxine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
16 42% Did not seem to work: 42%
Side effects too severe
15 39% Side effects too severe: 39%
Expense
6 16% Expense: 16%
Other
6 16% Other: 16%
Doctor's advice
5 13% Doctor's advice: 13%
Personal research
2 5% Personal research: 5%

See all 37 patients who’ve stopped taking Desvenlafaxine

Duration See details about how long patients take this treatment ▼

Currently Taking Desvenlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
9
23
41
15
1

Stopped Taking Desvenlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
13
13
8
3
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
37 93%
Usually
1 3%
Sometimes
0 0%
Never
2 5%

Burden

Difficulty being on treatment

Very
5 13%
Somewhat
3 8%
A little
5 13%
Not at all
27 68%

Cost

Paid out of pocket

$200+
1 3%
$100-199
0 0%
$50-99
4 10%
$25-49
9 23%
< $25
14 35%

Report created on November 21, 2009.